Divestment
MyCartis (Pronota)
MyCartis, formerly Pronota, develops biomarker diagnostics and multiplex platforms to advance personalized medicine.
Key Facts
- Sector
Life Sciences
- Country
Belgium
- Fund
LSP 3
- Entry
2006
- Exit
2017
Responsible Partner
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.